Tragiannidis, A.; Antari, V.; Tsotridou, E.; Sidiropoulos, T.; Kaisari, A.; Palabougiouki, M.; Vyzantiadis, T.-A.; Hatzipantelis, E.; Galli-Tsinopoulou, A.; Goussetis, E.
Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia. Hematol. Rep. 2024, 16, 579-584.
https://doi.org/10.3390/hematolrep16040056
AMA Style
Tragiannidis A, Antari V, Tsotridou E, Sidiropoulos T, Kaisari A, Palabougiouki M, Vyzantiadis T-A, Hatzipantelis E, Galli-Tsinopoulou A, Goussetis E.
Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia. Hematology Reports. 2024; 16(4):579-584.
https://doi.org/10.3390/hematolrep16040056
Chicago/Turabian Style
Tragiannidis, Athanasios, Vassiliki Antari, Eleni Tsotridou, Theodoros Sidiropoulos, Aikaterini Kaisari, Maria Palabougiouki, Timoleon-Achilleas Vyzantiadis, Emmanuel Hatzipantelis, Assimina Galli-Tsinopoulou, and Evgenios Goussetis.
2024. "Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia" Hematology Reports 16, no. 4: 579-584.
https://doi.org/10.3390/hematolrep16040056
APA Style
Tragiannidis, A., Antari, V., Tsotridou, E., Sidiropoulos, T., Kaisari, A., Palabougiouki, M., Vyzantiadis, T. -A., Hatzipantelis, E., Galli-Tsinopoulou, A., & Goussetis, E.
(2024). Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia. Hematology Reports, 16(4), 579-584.
https://doi.org/10.3390/hematolrep16040056